首页> 外文期刊>Life sciences >INHIBITION OF NITRIC OXIDE DOES NOT AFFECT REPERFUSION-INDUCED MYOCARDIAL INJURY, BUT IT PREVENTS LIPID PEROXIDATION IN THE ISOLATED RAT HEART
【24h】

INHIBITION OF NITRIC OXIDE DOES NOT AFFECT REPERFUSION-INDUCED MYOCARDIAL INJURY, BUT IT PREVENTS LIPID PEROXIDATION IN THE ISOLATED RAT HEART

机译:抑制一氧化氮不会影响再灌注所致的心肌损伤,但可以防止脂质过氧化作用在离体大鼠心脏中发生

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

To examine if inhibition of nitric oxide (NO) synthesis influences myocardial ischemia-reperfusion injury, male Sprague Dawley rats were administered the NO synthesis inhibitor N-nitro-L-arginine methyl ester (L-NAME, 10 mg/kg, i.p.) or saline 6 hours prior to excising the heart and aorta. Aortic ring contractile response to norepinephrine (NE) was more pronounced and relaxation in response to acetylcholine was abolished in L-NAME-treated group (P < 0.05 vs. saline-treated group), indicating inhibition of NO synthesis in the vascular tissues. In the isolated perfused Langendorff hearts, force of cardiac contraction (FCC) and coronary perfusion pressure (CPP) were higher and coronary flow was lower in the L-NAME-treated group, again suggesting inhibition of NO synthesis. Global ischemia (40 min) followed by reperfusion (30 min) resulted in a decrease in FCC and coronary flow and an increase in CPP in all hearts. Myocardial CK also decreased similarly in all hearts. However, ischemia-reperfusion-induced decline in myocardial superoxide dismutase (SOD) activity and increase in malondialdehyde were prevented in the L-NAME-treated group (P < 0.01 vs. saline-treated hearts). Thus treatment with L-NAME with resultant inhibition of NO synthesis does not affect ischemia-reperfusion-induced cardiac dysfunction and injury in the isolated rat hearts, although the reduction in SOD activity and the rise in lipid peroxidation following reperfusion are attenuated. [References: 24]
机译:为了检查一氧化氮(NO)合成的抑制是否影响心肌缺血/再灌注损伤,对雄性Sprague Dawley大鼠给药了NO合成抑制剂N-硝基-L-精氨酸甲酯(L-NAME,10 mg / kg,ip)或在摘除心脏和主动脉前6小时加入生理盐水。在L-NAME治疗组中,对去甲肾上腺素(NE)的主动脉环收缩反应更加明显,并且对乙酰胆碱的响应松弛被消除(与盐水治疗组相比,P <0.05),表明在血管组织中NO合成受到抑制。在分离的Langendorff灌注心脏中,L-NAME治疗组的心脏收缩力(FCC)和冠状动脉灌注压(CPP)较高,冠状动脉血流较低,这再次表明NO合成受到抑制。全脑缺血(40分钟),然后再灌注(30分钟),导致所有心脏的FCC和冠状动脉血流减少,CPP增加。所有心脏的心肌CK也类似地下降。但是,在L-NAME治疗组中,可防止缺血再灌注引起的心肌超氧化物歧化酶(SOD)活性下降和丙二醛升高(与盐水治疗的心脏相比,P <0.01)。因此,尽管抑制了SOD活性的降低和再灌注后脂质过氧化作用的升高,但用L-NAME进行的治疗却抑制了NO的合成,因此不会影响缺血再灌注引起的心脏功能障碍和离体大鼠心脏的损伤。 [参考:24]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号